Go back home

Item cover image

Using machine learning to design phages with enhanced therapeutic features


June 8, 2021 at 5:00 PM Pacific Time

Rob McBride Profile Image

Co-founder at Felix Biotechnology

Robert McBride is the co-founder at Felix Biotechnology. Felix Biotechnology is focused on accelerating the deployment of novel biotherapeutics targeting urgent microbial challenges in human health and beyond. Felix Biotechnology recently announced initiation of a clinical trial using phage for Pseudomonas infections.